Riskpilot← Back to searchSign inGet full accessBIOPORTO DIAGNOSTICS A/S
A/SActiveCVR 18645882Tuborg Havnevej 15, st.Research and experimental development on natural sciences and engineering · NACE 7210Est. 199527 employees
Revenue 2025
DKK 40,3M
+11% vs 2024
EBITDA margin
-171.1%
-12% vs 2024
Equity ratio
-3376.4%
Financial strength
Net profit 2025
DKK -81,4M
+27% vs 2024
| Revenue | DKK 40,3M | +11% |
| EBITDA | DKK -68,9M | -12% |
| Net profit | DKK -81,4M | +27% |
| Total assets | DKK 24,8M | +22% |
| Equity | DKK -837,6M | -11% |
| Employees | 27 | — |
Legal name
BIOPORTO DIAGNOSTICS A/S
CVR number
18645882
Legal form
Aktieselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
1. juli 1995
Share capital
DKK 4.750.000
Employees
27 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede bestyrelse, af bestyrelsesformanden sammen med en direktør eller af to direktionsmedlemmer i forening.
Company purpose
Selskabets formål er at drive forskning, handel, fabrikation og dermed beslægtet virksomhed primært inden for sundhedssektoren.
Address
Tuborg Havnevej 15, st.
Phone
+4545290000
Email
info@bioporto.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.858 | 16.625 | 18.705 | 20.383 | 20.720 | 25.977 | 25.896 | 26.621 | 23.204 | 24.254 | 28.969 | 30.958 | 36.243 | 40.287 |
| Staff expenses | -10.562 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -8.951 | -13.351 | -15.210 | -12.853 | -20.281 | -28.668 | -31.482 | -53.657 | -41.882 | -47.502 | -67.347 | -58.514 | -61.316 | -68.946 |
| Depreciation & amort. | -189 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -9.140 | -13.351 | -15.210 | -12.853 | -20.281 | -28.668 | -31.482 | -53.657 | -41.882 | -47.502 | -67.347 | -58.514 | -61.316 | -68.946 |
| Net financials | -7.215 | -8.506 | -9.718 | -11.452 | -12.405 | -13.283 | -17.071 | -19.358 | -4.961 | -12.734 | -19.923 | -50.465 | -55.093 | -17.952 |
| Profit before tax | -16.355 | -21.857 | -24.928 | -24.305 | -32.687 | -41.952 | -48.553 | -73.015 | -46.843 | -60.236 | -87.270 | -108.979 | -116.408 | -86.898 |
| Tax | -1.250 | -1.250 | -2.171 | -6.852 | -3.746 | -6.671 | -4.822 | -5.724 | -4.215 | -6.113 | -5.498 | -4.226 | -5.500 | -5.500 |
| Net profit | -15.105 | -20.607 | -22.757 | -17.453 | -28.940 | -35.281 | -43.730 | -67.291 | -42.628 | -54.123 | -81.772 | -104.753 | -110.908 | -81.398 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 10.371 | 19.727 | 13.023 | 14.061 | 13.719 | 22.902 | 18.672 | 18.389 | 22.019 | 22.985 | 12.785 | 14.396 | 20.389 | 24.807 |
| Equity | -125.824 | -146.432 | -170.439 | -187.892 | -216.120 | -250.977 | -294.708 | -361.998 | -404.626 | -458.749 | -540.521 | -645.274 | -756.183 | -837.581 |
| Long-term debt | 131.790 | 161.218 | 179.368 | 198.958 | 227.961 | 266.791 | 308.019 | 376.173 | 416.257 | 474.269 | 538.655 | 647.976 | 767.883 | 856.470 |
| Short-term debt | 4.405 | 4.941 | 4.093 | 2.994 | 1.878 | 7.089 | 5.360 | 4.214 | 10.387 | 7.464 | 14.651 | 11.694 | 8.689 | 5.918 |
| Total debt | 136.195 | 166.158 | 183.461 | 201.952 | 229.839 | 273.879 | 313.379 | 380.388 | 426.645 | 481.734 | 553.306 | 659.670 | 776.572 | 862.387 |
EBITDA margin
-171.1%
This company
15.8%
Market median
-1183% vs market
20122025
Equity ratio
-3376.4%
This company
38.2%
Market median
-8939% vs market
20122025
Return on equity
-8139809600.0%
This company
18.4%
Market median
-44238095752% vs market
20122025
Net profit margin
-202.0%
This company
8.1%
Market median
-2594% vs market
20122025
Asset turnover
1.62×
This company
1.12×
Market median
+45% vs market
20122025
Debt / equity
1.03×
This company
0.62×
Market median
-66% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SS Management | Management | 1995 | — | — |
PM Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
TB Management | Management | 1996 | — | — |
CB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
CE | Audit | 1995 | — | — |
TO Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
HL Management | Management | 2002 | — | — |
ER Chief Executive Officer | Chief Executive Officer | 2005 | — | — |
OC Management | Management | 2014 | — | — |
AP Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2024 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2007 | — | — | |
| Deputy Chairman | 2022 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2022 | — | — | |
| Chairman | 2023 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2013 | — | — | |
| Board of Directors | 2026 | — | — | |
| Chairman | 2002 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2005 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
BIOPORTO A/S | Company | 100.0% | 100.0% | 2004 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDIA-INVEST DANMARK A/S
BIOPORTO DIAGNOSTICS A/S Board members of BIOPORTO DIAGNOSTICS A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Steen Schierbeck | Management | 0 companies |
| Peter Mørch Eriksen | Chief Executive Officer | 0 companies |
| Torsten Bjørn | Management | 0 companies |
| Carsten Buhl | Chief Executive Officer | 0 companies |
| Carl Edvard Gudbergsen | Audit | 0 companies |
| Thea Olesen | Chief Executive Officer | 0 companies |
| Henrik Lasse Lindblad | Management | 0 companies |
| Eske Rygaard-Hjalsted | Chief Executive Officer | 0 companies |
| Otto Christian Aagaard Rasmussen | Management | 0 companies |
| Anthony Paul Pare | Chief Executive Officer | 0 companies |
| Gry Louise Husby Larsen | Chairman | 0 companies |
| John Patrick McDonough | Board of Directors | 0 companies |
| Knud Carsten Bernhard Lønfeldt | Chairman | 0 companies |
| Henrik Clausen | Deputy Chairman | 0 companies |
| Thomas Magnussen | Chairman | 0 companies |
| Neil Allan Goldman | Chairman | 0 companies |
| Jan Leth Christensen | Chairman | 0 companies |
| Lars Otto Uttenthal | Board of Directors | 0 companies |
| Torben Arnth Nielsen | Board of Directors | 0 companies |
| Klaus Juhl Wulff | Board of Directors | 0 companies |
| Christian Foldberg Rovsing | Chairman | 0 companies |
| Ole Larsen | Board of Directors | 0 companies |
| Niels Jørgen Høy Nielsen | Board of Directors | 0 companies |
| Nis Glavind Kruse | Board of Directors | 0 companies |
| Claus Henrik Jepsen | Board of Directors | 0 companies |
| Lars Heslet | Board of Directors | 0 companies |